Novellia Beauty

Novellia is a rejuvenation biotechnology company founded by UC Berkeley researchers Drs. Michael and Irina Conboy to translate their breakthroughs in systemic aging into therapeutic and consumer products. The company’s core philosophy centers on the dilution of pro-aging factors in the blood, a concept derived from their seminal work on heterochronic parabiosis and Neutral Blood Exchange (NBE). Novellia currently markets a line of advanced skincare products that utilize these scientific insights to target the molecular drivers of skin aging. Additionally, the company supports the development of systemic therapies aimed at reversing age-related tissue degeneration and improving overall healthspan. By modulating systemic signaling pathways, Novellia aims to reset the regenerative capacity of aged tissues.